Introduction {#sec1-1}
============

Vitamin D is a pre-hormone synthesized mainly following the skin's exposure to solar UV radiation (UV-B), or alternatively found naturally in some foods and ingested from supplementation (Tagliabue et al., 2015). On the skin, it is synthetized as 7-dehydrocholesterol, so this compound is converted by UV into cholecalciferol, which is then transported to the liver associated with DBP (vitamin D carrier protein). The product of hydroxylation in the liver is termed 25-hydroxyvitamin D (25OHD), which is the most abundant form of the vitamin and is the circulating marker used to determine its sufficiency (Bikle, 2014). Circulating 25OHD is transported to the kidneys by vitamin D binding (DBP), where conversion to calcitriol or 1,25-dihydroxyvitamin D \[1,25(OH)2D\] occurs. This metabolite, due to its liposolubility, is associated with the vitamin D receptor (VDR - nuclear cell receptor group), which will consequently trigger and mediate genomic effects at the cellular level (Bandera et al., 2017). Due to its genomic role, in the last 10 years vitamin D has been identified as a possible therapeutic target for cancer, since it influences the transcription of genes involved in the process of cell growth and differentiation (Richards et al., 2015; Moukayed and Grant, 2017; Rosen et al., 2012).

More recently, low levels of circulating vitamin D in the population have been identified as a risk factor for tumors in general, especially breast cancer, but this association of risk is still controversial (Eliassen et al., 2016; Acevedo et al., 2016). On the other hand, high levels of vitamin D have contributed to better prognosis and overall survival for breast cancer cases (Yao et al., 2017; Villaseñor et al., 2013), and have even reduced the ability of metastasis in in vitro and in vivo assays (Wilmanski et al., 2016; Williams et al., 2016).

In Brazil, breast cancer is the most common tumor affecting women, comprising about 28% of all tumors diagnosed annually, excluding skin tumors (non-melanoma) (INCA, 2017). With the improvement of breast cancer screening, more impalpable breast lesions suspicious of cancer have been detected (Delmonico et al., 2015; Romeiro et al., 2016). The aim of this study was to evaluate the serum levels of vitamin D (25OHD) in patients with impalpable breast lesions comparing with a control group.

Materials and Methods {#sec1-2}
=====================

Study population {#sec2-1}
----------------

Patients were recruited from 2008 to 2016 at Hospital Gafrée-Guinle University Hospital (HUGG) and at Americas Barra Medical City (Maurício Magalhães Costa Clinic), in the city of Rio de Janeiro, Brazil. All patients provided written informed consent. The study was conducted according to the guidelines of the Declaration of Helsinki. This study was approved by the ethics committee of both institutions (HUGG-07/2007-80/2012 and Rio de Janeiro State University 43560115.5.0000.5259). All patients were diagnosed with impalpable lesions BIRADS (Breast imaging-reporting and data system) grade 4. Following biopsy or surgery, the lesion was classified as malignant (N =58) or benign (N=7). Data on age, tumor classification, grade, size, nodal involvement, and immunohistochemical profile were obtained from participating institutions. Histologic classification was graded according to current (2012) World Health Organization criteria (Lakhani et al., 2012), and nuclear grade was defined as grades I to III according to Elston and Ellis (Elston and Ellis, 1991). The histologic classification and the nuclear grading were performed by a medical pathologist. Peripheral blood of 20 eligible healthy women (controls) was collected in Rio de Janeiro.

Laboratory analysis {#sec2-2}
-------------------

Four mL of blood was collected in EDTA and centrifuged at room temperature for 10 minutes at 2,000 g and plasma was stored at -80°C. We measured serum 25-hydroxyvitamin D (25OHD) using the Roche Elecsys Vitamin D Total assay (Roche Diagnostics, Mannheim, Germany). The measurements were performed on the Modular Cobas E601 Analyzer according to the manufacturer's protocol. Serum concentrations below 20 ng/mL (50 nmol/L) were classified as deficiency, ≥20 ng/mL (50 to 74 nmol/L) as insufficiency, and ≥30 ng/mL (≥75 nmol/L) as sufficiency (Holick, 2006; Holick et al., 2011).

Statistical Analysis {#sec2-3}
--------------------

Calculation of the sample size {#sec2-4}
------------------------------

The calculation of the sample size required to establish the chi-square test depends on the specification of the following parameters, described in the literature according to Cohen (1988): a) Level of significance is 5% (α = 0.05 two-sided); b) for the measurement of the effect, the value described in the literature, according to Cohen (1988), was considered the following reference value: medium effect = 0.30; c) test power (1-β): β = 0.25; d) degree of freedom equal to 1, since each variable has two categories. These parameters showed that the sample size is 77 individuals.

Analysis of vitamin D levels {#sec2-5}
----------------------------

Initially, an exploratory analysis was carried out to characterize the patients' sample, using frequency distributions and descriptive measures for the clinical variables.

For a bivariate analysis, individuals with vitamin D deficiency and insufficiency were grouped into a single group (I/D) due to the number of cases evaluated here. The Fischer chi-square or Pearson test was used for the evaluation of differences between the benign/malignant lesions and control group regarding the vitamin D levels. It was calculated the odds ratio for significance chi-square test.

For the associations between deficient and insufficient in control group and cases, the parametric t-Student test was used to determine differences of 25(OH)D concentrations.

The optimal cut-off point for sensitivity and specificity to evaluate the correlation between vitamin sufficiency and the age was done using the receiver operating characteristic (ROC curve). A contingency table was used to associate the age variable with the presence of sufficient amount of vitamin D. The chi-square or Fisher's Exact test was used to test the statistical significance of the association between these variables. The odds ratio for the occurrence of clinical events was calculated by comparing the age groups. The 95% confidence interval was obtained for the odds ratio.

The data were processed in the statistical program Predictive Analytics Software (PASW 18). A level of significance of 5% was considered in all the statistical tests used. Statistically significant data were considered as those whose P value was less than 0.05.

Results {#sec1-3}
=======

Our study quantified vitamin D in 58 women with malignant breast lesions, which included 45/58 (77%) Luminal A/B, 8/58 (14%) HER positive, 5/58 (9%) triple negative, and 7 cases with benign breast lesions. The mean age was 59 years (SD 12.66), 62 (SD 12.58), 43 (SD 3.07), and 46 (SD 6.96) for the Luminals A/B, HER2, triple negative, and benign lesions, respectively. The mean age of the control group was 37 years (SD 11.31). Clinical-pathological variables of cases are summarized in [Table 1](#T1){ref-type="table"}.

###### 

Clinical Data of the Cases with Malignant Impalpable Lesion Evaluated in This Study

  Age                                                                                        Mean (years)    
  ------------------------------------------------------------------------------------------ --------------- -----
   Luminal A/B                                                                               59 (SD 12.66)   
   HER2                                                                                      62 (SD 12.58)   
   Triple Negative                                                                           43 (SD 3.07)    
                                                                                             Patients N=58   \%
  Histopathologic grade                                                                                      
   I                                                                                         13              22%
   II                                                                                        28              49%
   III                                                                                       17              29%
  Molecular classification                                                                                   
   Luminal A/B                                                                               45              77%
   HER2                                                                                      8               14%
   Triple negative                                                                           5               9%
  Histopathologic classification                                                                             
   IDC                                                                                       36              62%
   DCIS                                                                                      5               9%
   IDC-DCIS                                                                                  6               10%
   ILC                                                                                       2               3%
  Other malignant lesions (LCIS, Mucinous carcinoma, micropapillary carcinoma, and others)   9               16%

IDC, infiltrative ductal carcinoma; DCIS, ductal carcinoma *in situ*; ILC, infiltrative lobular carcinoma; LCIS, infiltrative carcinoma *in situ*

Regarding vitamin D dosage, 49/58 (84%) of patients with malignant tumors presented deficiency and/or insufficiency, of which 30/58 (65%) were Luminals A/B. All patients with HER2 (n=8) and triple negative (n=5) tumors had insufficiency and/or deficiency as well.

Using the chi-square test, the vitamin D levels were compared between groups, malignant and benign lesions versus control, and between subtypes of breast cancer versus control. These associations are summarized in [Table 2](#T2){ref-type="table"}.

###### 

Association of the Control Group with the Benign and Malignant Lesions Regarding the Levels of Vitamin D

  Variable                   Vitamin D   P value    
  -------------------------- ----------- ---------- -------
  Controls (N=20)            12 (60%)    8 (40%)    0.363
  Benign lesions (N=7)       6 (86%)     1 (14%)    
  Controls (N=20)            12 (60%)    8 (40%)    0.255
  Malignant lesions (N=57)   49 (86%)    8 (14%)    
  Controls (N=20)            12 (60%)    8 (40%)    0.779
  Luminals A/B (N=45)        30 (67%)    15 (33%)   
  Controls (N=20)            12 (60%)    8 (40%)    0.063
  HER2 (N=8)                 8 (100%)    0 (0%)     
  Controls (N=20)            12 (60%)    8 (40%)    0.140
  Triple negative (N=5)      5 (100%)    0 (0%)     

I, insufficient; D, deficient; S, sufficient. \*The probability of significance (P-value) refers to the chi-square test.

The results of associations between deficient and insufficient 25(OH)D concentrations and case and control are described in [Table 3](#T3){ref-type="table"}. There was no statistical association of deficiency and insufficiency between groups.

###### 

Associations between Deficient and Insufficient 25(OH)D Concentrations in Control Group and Cases

  Groups[\*](#t3f1){ref-type="table-fn"}   Number of cases   Mean (ng/mL)   SD     t-student test   P-value[\*\*](#t3f2){ref-type="table-fn"}
  ---------------------------------------- ----------------- -------------- ------ ---------------- -------------------------------------------
  Benign lesions                           6                 17.83          7.60   0.336            0.741
  Controls                                 12                18.88          5.84                    
  Luminal A/B                              30                20.29          5.66   0.751            0.457
  Controls                                 12                18.88          5.84                    
  HER2                                     8                 17.13          7.26   0.621            0.542
  Controls                                 12                18.88          5.84                    
  Triple Negative                          5                 17.60          5.03   0.433            0.670
  Controls                                 12                18.88          5.84                    
  Luminal                                  30                20.29          5.66   0.908            0.371
  Benign lesions                           6                 17.83          7.60                    
  HER2                                     8                 17.13          7.26   0.177            0.862
  Benign lesions                           6                 17.83          7.60                    
  Triple Negative                          5                 17.60          5.03   0.059            0.955
  Benign lesions                           6                 17.83          7.60                    
  Luminal A/B                              30                20.29          5.66   0.990            0.330
  Triple Negative                          5                 17.60          5.03                    
  Luminal A/B                              30                20.29          5.66   1.308            0.200
  HER2                                     8                 17.13          7.26                    
  Triple Negative                          5                 17.60          5.03   0.127            0.901
  HER2                                     8                 17.13          7.26                    

SD, standard deviation,

Only deficiency and insufficiency cases of vitamin D,

The probabilities of significance (P-value) refer to the t-Student test for independent samples

The relationship between vitamin D levels and age presented significant association only for the control group (P=0.002). For this reason, according to the ROC plot area (0.778) of the control group, a cut-off value of 45 years old for women was determined, with specificity and sensitivity of 60% and 50%, respectively ([Figure 1](#F1){ref-type="fig"}). Once the 45-year cutoff point was determined, the odds ratio for vitamin D insufficiency in women over 45 years of age was 1.37 (P=0.011).

![ROC Curve of Association between Age and Vitamin D Quantification for the Control Group](APJCP-19-3087-g001){#F1}

The statistical relationship between sufficiency and deficiency/insufficiency of vitamin D for different types of histological grade (P=0.102), and lymph node involvement (P=1.00) did not show any significant association, according to the chi-square test.

Discussion {#sec1-4}
==========

This study revealed low levels of vitamin D in a heterogeneous group of women with impalpable breast lesions and in the controls as well. Although vitamin D deficiency is a widespread health problem, it has been gaining prominence in regions where sunshine prevails all the year (Schoenmakers et al., 2008). Indoor lifestyles, urban living, and nutrition may explain this finding (Arabi et al., 2010). Nevertheless, low levels of vitamin D were positively associated with aging only in the control group.

Based on our previous study, the vitamin D-binding protein level was considered a candidate to differentiate patients with breast impalpable lesions from controls. A nano-liquid chromatography-quadrupole-time-of-flight (nLC-Q-TOF) technology was used, and vitamin D-binding protein was found down expressed in the plasma of cases with benign and malignant breast lesions in comparison with controls´ plasmas (Delmonico et al., 2016). In view of these findings, vitamin D-binding protein should be validated as a putative biomarker in a future study.

With regard to the Brazilian population, two reports evaluated breast cancer and vitamin D deficiency (de Lyra et al., 2006; Oliveira et al., 2016). Lyra (2006) studied the levels of 1,25(OH)2D3 and 25OHD in 88 women with breast cancer and 35 controls (submitted to mammoplasties or resection of benign lesions) in the city of São Paulo. These authors found no significant difference between the groups (P= 0.722). Further, when they evaluated the differences in vitamin D levels according to the histological grade of the tumor, no significant difference was found between grade tumors I/II (P=0.329) and III/IV (P=0.256). These results were similar to those of our study, in which no significant difference was detected for the different degrees of tumors (P=0.102) and lymph node involvement (P=1.00). On the other hand, the second Brazilian study, conducted in Belo Horizonte city, evaluating 181 women with breast cancer and 197 controls, determined that the levels of vitamin D sufficiency (P=0.012) and the moderate practice of physical activity (P=0.037) were protective variables for breast cancer (Oliveira et al., 2016).

Considering population studies from other countries, Acevedo (2016) reported that 98/105 (93.3%) Chilean women with breast cancer and 88/93 (94.6%) of cases with Luminal A/B tumors had vitamin D insufficiency/deficiency (≤29.9 ng / mL). Further, 51/53 (96%) of histological grade 3 tumors showed levels of vitamin D in the same range of insufficiency. In our study, these values were lower, with 30/45 (67%) of the Luminal tumors A/B and 15/17 (88%) from grade 3 tumors (see [Table 3](#T3){ref-type="table"}). In the study by Bilinski and Boyages (2013), 217 Australian women with breast cancer and 852 controls had vitamin D insufficiency with rates of 39.7% (85/214) and 32.3% (275/852), respectively. We found a higher value, being 49/65 (75%) and 12/20 (60%) for malignant tumors and controls, respectively.

The low levels of Vitamin D herein presented for the control group, as well as for the other studies (Oliveira et al., 2016; Bilinski et al., 2013; Unger et al., 2010), are alarming. These values become more evident in countries whose sun incidence is low or that have periods of rigorous winter (Nouri et al., 2017; Shirazi et al., 2016). Consequently, we believe that a part of the global population may be experiencing hypovitaminosis D, increasing the susceptibility to development of the carcinogenic process and other diseases. In relation to the carcinogenic process, the studies with larger numbers of evaluated cases have highlighted low levels of vitamin D as a risk factor for breast cancer (Rose et al., 2013), colorectal cancer (Maalmi et al., 2014), and haematological tumors (Wang et al., 2015). In addition, low levels of vitamin D were associated with the lower overall survival rate (OS) and the lower rate of disease-free survival (RFS) in these tumors.

An equally important finding here was the relationship between the low levels of vitamin D and aging. One reason why vitamin D tends to decrease with aging is directly related to the decreasing capacity to produce vitamin D3, due to degeneration in the cutaneous levels of 7-dehydrocholesterol (Bolland et al., 2006; Bolland et al., 2007). Two other reasons associated with decreasing vitamin D in the elderly are the increase of fat mass and the decrease of sun exposure. The first is related to the number of adipocytes that sequester vitamin D naturally, ingested or produced in the skin, before being transported to the liver to be converted to 25(OH)D3 (Bolland et al., 2007); and the second that elderly tend to wear more clothing and spend more time indoors due to reduced walking capacity (Unger et al., 2010).

This study is original in that it shows that vitamin D deficiency is prevalent lower in women with impalpable breast lesions and that vitamin levels are directly related to aging. We emphasize the need for monitoring vitamin D levels especially in the elderly, even in sunny countries, to prevent diseases such as cancer.
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